251 related articles for article (PubMed ID: 35330864)
1. The role of microRNA in the pathogenesis of glial brain tumors.
Beylerli O; Gareev I; Sufianov A; Ilyasova T; Zhang F
Noncoding RNA Res; 2022 Jun; 7(2):71-76. PubMed ID: 35330864
[TBL] [Abstract][Full Text] [Related]
2. Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment.
Mafi A; Rahmati A; Babaei Aghdam Z; Salami R; Salami M; Vakili O; Aghadavod E
Cell Mol Biol Lett; 2022 Aug; 27(1):65. PubMed ID: 35922753
[TBL] [Abstract][Full Text] [Related]
3. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.
Ghaemmaghami AB; Mahjoubin-Tehran M; Movahedpour A; Morshedi K; Sheida A; Taghavi SP; Mirzaei H; Hamblin MR
Cell Commun Signal; 2020 Aug; 18(1):120. PubMed ID: 32746854
[TBL] [Abstract][Full Text] [Related]
4. MiR-21: A key player in glioblastoma pathogenesis.
Masoudi MS; Mehrabian E; Mirzaei H
J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
[TBL] [Abstract][Full Text] [Related]
5. miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
Ames H; Halushka MK; Rodriguez FJ
J Neuropathol Exp Neurol; 2017 Apr; 76(4):246-254. PubMed ID: 28431179
[TBL] [Abstract][Full Text] [Related]
6. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Human Malignant Gliomas.
Mizoguchi M; Guan Y; Yoshimoto K; Hata N; Amano T; Nakamizo A; Sasaki T
J Oncol; 2012; 2012():732874. PubMed ID: 22848219
[TBL] [Abstract][Full Text] [Related]
9. Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells.
Tűzesi Á; Kling T; Wenger A; Lunavat TR; Jang SC; Rydenhag B; Lötvall J; Pollard SM; Danielsson A; Carén H
Oncotarget; 2017 Oct; 8(52):90164-90175. PubMed ID: 29163818
[TBL] [Abstract][Full Text] [Related]
10. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.
Cheng J; Meng J; Zhu L; Peng Y
Mol Cancer; 2020 Mar; 19(1):66. PubMed ID: 32213181
[TBL] [Abstract][Full Text] [Related]
11. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
Santangelo A; Imbrucè P; Gardenghi B; Belli L; Agushi R; Tamanini A; Munari S; Bossi AM; Scambi I; Benati D; Mariotti R; Di Gennaro G; Sbarbati A; Eccher A; Ricciardi GK; Ciceri EM; Sala F; Pinna G; Lippi G; Cabrini G; Dechecchi MC
J Neurooncol; 2018 Jan; 136(1):51-62. PubMed ID: 29076001
[TBL] [Abstract][Full Text] [Related]
12. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
13. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas].
Gareev IF; Novicova LB; Beylerli OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):86-90. PubMed ID: 31317895
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
[TBL] [Abstract][Full Text] [Related]
15. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
16. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).
Yang CH; Yue J; Pfeffer SR; Fan M; Paulus E; Hosni-Ahmed A; Sims M; Qayyum S; Davidoff AM; Handorf CR; Pfeffer LM
J Biol Chem; 2014 Sep; 289(36):25079-87. PubMed ID: 25059666
[TBL] [Abstract][Full Text] [Related]
18. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
19. The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.
Beyer S; Fleming J; Meng W; Singh R; Haque SJ; Chakravarti A
Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28698530
[TBL] [Abstract][Full Text] [Related]
20. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
